Background and Aims: Inflammatory bowel disease [IBD] patients are still under-diagnosed or diagnosed with serious delay. We examined whether diagnostic delay [DD] in IBD has changed over the last 60 years, and explored the risk factors of longer DD. Methods: In total, 3392 IBD patients recorded in the registry of four IBD Italian centres were divided according to the year of diagnosis into a historical cohort [HC: 1955-84] and modern cohort [MC: 1985[MC: -2014. DD, i.e. time lapse between onset of symptoms indicative of IBD and definitive diagnosis, was divided into four sub-periods [0-6, 7-12, 13-24, >24 months], which were correlated with age and disease location/behaviour at diagnosis. Results: Median DD in IBD was 3.0 months, it was significantly [P < 0 [1985-94: 19.9%; 1995-2004: 16.4%; 2005-14: 13.9%; P = 0.04]. At logistic regression analysis, age at diagnosis >40 years (CD: odds ratio 1.73, 95% confidence interval [CI] 1.31-2.28, P < 0.0001; UC: 1.41, 95% CI 1.02-1.96, P = 0.04) and complicated disease at CD diagnosis [1.39, 95% CI 1.06-1.82, P = 0.02] were independently associated with a DD>24 months. Conclusions: DD duration has not changed over the last 60 years in Italy, but the number of IBD patients with a longer DD significantly decreased. Older age at diagnosis and a complicated disease at CD diagnosis are risk factors for longer DD.
Introduction
The incidence of inflammatory bowel disease [IBD] is increasing worldwide.
1 Both Crohn's disease [CD] and ulcerative colitis [UC] are therefore becoming an important public health issue. A delay in diagnosis is considered a risk factor for the development of complications and abdominal surgery. 2, 3 In IBD, a considerable diagnostic delay [DD] is documented in a growing number of studies. [2] [3] [4] [5] [6] The DD, defined as the time interval between the first likely symptoms and diagnosis, includes both the time patients take before consulting a physician and the time required by physicians to diagnose IBD. The latter time period seems to be prolonged, 3 probably because of the overlap of IBD symptoms with other concomitant disorders, especially irritable bowel syndrome [IBS] , thus complicating the physician's ability to make a prompt diagnosis.
On this basis, the primary aim of our study was to evaluate whether the DD is a relevant issue in IBD in Italy by retrospectively reporting data of a large cohort of patients over quite a long time period [six decades]. The secondary aim was to identify putative risk factors for a longer DD.
Methods

Patients
Cases included the entire IBD population recorded in the registry of four North-Central Italian IBD referral Centres [San Camillo Forlanini Hospital, Rome; San Filippo Neri Hospital, Rome; San Matteo Hospital Foundation, Pavia; Luigi Sacco University Hospital, Milan] between 1955 and 2014. Over this 60-year period, we identified two cohorts, one belonging to the first three decades , namely the historical cohort [HC] ) and the other belonging to the succeeding three decades , namely the modern cohort [MC]). Patients for whom the date of symptom onset was not available [namely 513 in the HC and 107 in the MC] were excluded from the study. We calculated the DD as the time lapse between the onset of symptoms indicative of either CD or UC and the final diagnosis. The DD was divided into four sub-periods [0-6, 7-12, 13-24 and > 24 months]. The diagnosis was based on clinical and histological criteria. Disease location and extent were confirmed by endoscopy in UC, and by endoscopy plus imaging in CD, while disease behaviour was assessed by imaging. IBD location and behaviour at diagnosis were defined according to the Montreal classification. 7 In a sub-cohort of 558 patients we analysed the results by splitting the overall DD into 'patient-dependent' and 'physician-dependent'. The former was defined as the time from the symptoms' appearance to the first medical consultation, while the second was defined as the time from the first medical consultation to the final diagnosis. In this patient sub-cohort, we also evaluated the number and type of misdiagnoses. Referral practice and registration modalities were comparable between the four Centres.
Statistical analysis
The results are expressed as either median plus interquartile range [IQR] for non-parametric data, or mean ± standard deviation [SD] for parametric data. Categorical data were summarized as the percentage of the total group. Differences in quantitative data distributions between patient sub-groups were compared using Student's t-test for parametric data, and by the Wilcoxon rank-sum test for non-parametric data. Differences in frequencies for categorical data were compared using the χ 2 test. Logistic regression analysis evaluating the DD as a dependent variable with potential associated factors was performed applying stepwise regression modelling. We tested each factor separately, and we entered all risk factors with a p-value <0.2 in a multivariate logistic regression modelling. A p-value of <0.05 was considered statistically significant.
Results
Baseline patient characteristics
A total of 3392 IBD patients were included in the study [ Table 1 ]. The HC consisted of 481 patients while the MC consisted of 2911 patients. No significant difference was found in sex distribution and age at diagnosis between the two cohorts, but there was a significantly higher proportion of CD patients than UC patients in the HC. No significant difference was found in CD location or UC extension, but a significantly higher proportion of CD patients with stricturing behaviour [B2] was identified in the HC, while a significantly higher proportion of inflammatory behaviour [B1] was observed in the MC. When we compared IBD patients coming from urban and rural areas, the DD did not significantly differ.
Length of DD
Patient distribution in the DD sub-periods
When we analysed the results according to the four DD sub-periods [0-6, 7-12, 13-24, > 24 months], we found that there was a significant [p < 0.0001] difference in the distribution of IBD patients in the four sub-periods in the HC vs the MC [ Table 2 ]. In particular, in the MC the percentage of patients with a DD>24 months was lower in comparison to those belonging to the HC. This trend was still evident and significant within the last three decades [ Table 2 ]. Moreover, the distribution of the entire IBD population in the four sub-periods was different in CD and UC, with a higher proportion of patients having a DD>24 months in the CD sub-group [ Table 2 , when we looked at the distribution of the IBD patients belonging to the MC in the four DD sub-periods according to IBD type, we found no significant difference among the last three decades either in CD or in UC.
Risk factors for a longer DD in the last three decades
In the CD patients belonging to the MC, we found no significant difference in the median DD according to gender, CD location or CD disease behaviour at diagnosis. CD patients with an age at diagnosis > 40 years had a median DD (6 months [IQR 1-23] ) that was significantly [p < 0.001] higher than those with an age at diagnosis ≤ 40 years (2 months [QR 2-37]). We then applied a multivariate logistic regression model to investigate the relationship between DD duration and potential risk factors such as gender, decade of diagnosis, age at diagnosis, disease location and behaviour at diagnosis [ Table 4 ]. At logistic regression analysis, age at diagnosis > 40 years (odds ratio 1.73, 95% confidence interval [CI] 1.31-2.28; p < 0.0001) and complicated disease defined by a B2+B3 phenotype [odds ratio 1.39, 95% CI 1.06-1.82, p = 0.02] were independently associated with a DD>24 months in CD patients. As regards UC, we observed no significant difference in the median DD according to decade of diagnosis, gender, age at diagnosis and disease extension at diagnosis. At multivariate logistic regression analysis in UC patients, 
Discussion
This is the first study exploring the DD and its risk factors in a large cohort of IBD patients across an extended time period. We here confirmed the results of previous papers 2, 6, 8, 9 by showing that median DD is significantly longer in CD than in UC. Of note, the proportion of patients in our study having a DD>24 months was higher in CD than in UC. These results, which are in keeping with those reported in the Swiss IBD cohort study, 10 reflect the typical clinical presentation of CD characterized by a poor correlation between symptoms and lesions, and do fit with the higher rate of misdiagnoses we reported in CD in comparison to UC, in accordance with the literature. [10] [11] [12] The fact that DD has not changed over the last six decades provides strong-even if indirect-evidence that the increased incidence of IBD, reported in Italy by two contemporary studies on paediatric and adult populations, 13, 14 may not be significantly driven by earlier diagnosis but by a true rise of incidence. More than one-third of the misdiagnoses in CD were IBS; however, this does not help in explaining the longer DD in CD patients, since IBS has a comparable frequency as a misdiagnosis in both CD and UC. The lack of change in the DD despite the modern awareness of the disease, the advancement of diagnostic modalities and the better accessibility of medical care could be theoretically related to the fact that, compared to six decades ago, there are now more IBS cases, which make physicians more likely to attribute patients' symptoms to IBS instead of working them up for IBD than physicians 60 years ago. However, the results of our sub-analysis showing that the DD is not physician-but patient-related make this hypothesis quite unlikely.
In the CD sub-group, we found an association between DD duration and disease behaviour at diagnosis. In particular, we found a significantly higher prevalence of a complicated disease at diagnosis in patients having a DD>24 months. This result, which seems paradoxical at a first glance, might be explained by the fact that stricturing disease often manifests with abdominal pain when the disease is already advanced, while intra-abdominal fistulas are frequently asymptomatic until an abscess forms. Moreover, these data confirm previous findings showing a higher risk for intestinal strictures and CD-related intestinal surgery in patients experiencing a longer DD, 15, 16 and thus a poorer outcome. 17 Unexpectedly, in contrast to the unchanged median duration of the DD between the HC and MC and between the last three decades, we noticed a progressive decrease of the proportion of patients with a DD>24 months in the transit from the HC to the MC, and the magnitude of this reduction remained significant over the last three decades. Greater awareness for IBD could be a possible explanation for the decreased number of patients with a longer DD. While we acknowledge that the disproportion between the HC and MC, mostly due to the difficulty in obtaining comprehensive patient data from old paper-based records, might represent a possible confounding factor of our study, it did give us the chance to explore an era which is greatly under-represented in the literature.
When we split the overall DD into patient-dependent and physician-dependent intervals, we found that the former is about three times longer than the latter. A possible explanation for this could be the quite high prevalence of IBS-like symptoms at IBD onset, 18, 19 which may be underestimated by the patient him/herself. Another possible reason could be the difficulty that patients have in accessing the healthcare system. However, in Italy since 1978 the Italian National Health System has been based on the principle of social solidarity, and it guarantees free access to family doctors and specialists for all citizens, regardless of employment status. Our results are in contrast with those reported in a paediatric study, in which the physician-dependent DD was significantly longer than that depending on the patient. 9 Therefore, while increasing paediatricians' awareness and faecal calprotectin use as a first-line test could be recommended strategies in this setting to diminish the physiciandependent DD, it is not yet clear what is the best strategy to affect the patient-dependent DD in adulthood.
In conclusion, our data show that DD did not change in terms of duration in IBD Italian patients over the last 60 years. However, the proportion of IBD patients with a longer DD significantly decreased between the HC and MC, and even over the last three decades. Increased awareness for the disease in parallel with an increasing incidence might play a major role in decreasing diagnostic delay. DD is longer in CD than in UC, is associated with an older age and a complicated disease at diagnosis, and it is more influenced by the delay with which the patient contacts the doctor than by the time the physician needs to make the right diagnosis. This latter observation makes the hypothesis regarding the possible attribution of symptoms to IBS by physicians quite unlikely. Awareness campaigns extended to all specialists, surgeons and family doctors, prevention strategies aimed at achieving a very early diagnosis, 20 and the use of widely accessible, non-invasive and cost-effective diagnostic tools might be helpful in reducing at least the physician-dependent DD. Recently, a predictive score based on CD patient symptoms 21 and an eight-item questionnaire for IBD patients along with the evaluation of faecal calprotectin 22 have been proposed as simple and low-cost tools for diagnosing IBD patients earlier. An earlier diagnosis is crucial also for UC patients, since a delayed diagnosis, and in particular a delay of more than 2 months in the introduction of mesalamine, represents a risk factor for a disabling disease course. 23 
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